Anstee QM - Search Results

1

Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests.

Masoodi M, Gastaldelli A, Hyötyläinen T, Arretxe E, Alonso C, Gaggini M, Brosnan J, Anstee QM, Millet O, Ortiz P, Mato JM, Dufour JF, Orešič M. Masoodi M, et al. Among authors: anstee qm. Nat Rev Gastroenterol Hepatol. 2021 Dec;18(12):835-856. doi: 10.1038/s41575-021-00502-9. Epub 2021 Sep 10. Nat Rev Gastroenterol Hepatol. 2021. PMID: 34508238 Review.

2

The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studies.

Al-Serri A, Anstee QM, Valenti L, Nobili V, Leathart JB, Dongiovanni P, Patch J, Fracanzani A, Fargion S, Day CP, Daly AK. Al-Serri A, et al. Among authors: anstee qm. J Hepatol. 2012 Feb;56(2):448-54. doi: 10.1016/j.jhep.2011.05.029. Epub 2011 Jul 12. J Hepatol. 2012. PMID: 21756849

3

Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease.

Hallsworth K, Hollingsworth KG, Thoma C, Jakovljevic D, MacGowan GA, Anstee QM, Taylor R, Day CP, Trenell MI. Hallsworth K, et al. Among authors: anstee qm. J Hepatol. 2013 Apr;58(4):757-62. doi: 10.1016/j.jhep.2012.11.015. Epub 2012 Nov 22. J Hepatol. 2013. PMID: 23178979

4

Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?

McPherson S, Anstee QM, Henderson E, Day CP, Burt AD. McPherson S, et al. Among authors: anstee qm. Eur J Gastroenterol Hepatol. 2013 Jun;25(6):652-8. doi: 10.1097/MEG.0b013e32835d72cf. Eur J Gastroenterol Hepatol. 2013. PMID: 23325287

5

Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis.

Anstee QM, Targher G, Day CP. Anstee QM, et al. Nat Rev Gastroenterol Hepatol. 2013 Jun;10(6):330-44. doi: 10.1038/nrgastro.2013.41. Epub 2013 Mar 19. Nat Rev Gastroenterol Hepatol. 2013. PMID: 23507799 Review.

6

The genetics of NAFLD.

Anstee QM, Day CP. Anstee QM, et al. Nat Rev Gastroenterol Hepatol. 2013 Nov;10(11):645-55. doi: 10.1038/nrgastro.2013.182. Epub 2013 Sep 24. Nat Rev Gastroenterol Hepatol. 2013. PMID: 24061205 Review.

7

Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease.

McPherson S, Henderson E, Burt AD, Day CP, Anstee QM. McPherson S, et al. Among authors: anstee qm. J Hepatol. 2014 May;60(5):1055-62. doi: 10.1016/j.jhep.2014.01.010. Epub 2014 Jan 18. J Hepatol. 2014. PMID: 24445215

8

Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma.

Liu YL, Patman GL, Leathart JB, Piguet AC, Burt AD, Dufour JF, Day CP, Daly AK, Reeves HL, Anstee QM. Liu YL, et al. Among authors: anstee qm. J Hepatol. 2014 Jul;61(1):75-81. doi: 10.1016/j.jhep.2014.02.030. Epub 2014 Mar 6. J Hepatol. 2014. PMID: 24607626

9

TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease.

Liu YL, Reeves HL, Burt AD, Tiniakos D, McPherson S, Leathart JB, Allison ME, Alexander GJ, Piguet AC, Anty R, Donaldson P, Aithal GP, Francque S, Van Gaal L, Clement K, Ratziu V, Dufour JF, Day CP, Daly AK, Anstee QM. Liu YL, et al. Among authors: anstee qm. Nat Commun. 2014 Jun 30;5:4309. doi: 10.1038/ncomms5309. Nat Commun. 2014. PMID: 24978903 Free PMC article.

10

Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management.

McPherson S, Hardy T, Henderson E, Burt AD, Day CP, Anstee QM. McPherson S, et al. Among authors: anstee qm. J Hepatol. 2015 May;62(5):1148-55. doi: 10.1016/j.jhep.2014.11.034. Epub 2014 Dec 1. J Hepatol. 2015. PMID: 25477264 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

256 results

Search Page